Malaria is the leading cause of morbidity and mortality in children under five in Malawi. There are approximately five million episodes of malaria per year. It is endemic in 95% of the country, with 98% of infections due to Plasmodium falciparum, the most severe form of the four human malarial species. The Ministry of Health (MOH) estimates that malaria accounts for 34% of all outpatient visits and 40% of all hospital admissions among children under five. Four out of ten hospital deaths are reported to be due to malaria.
With nearly $158 million in investment between 2006 and 2013, the USG’s Presidential Malaria Initiative (PMI) has contributed to substantial scaling-up of malaria prevention and control interventions in Malawi.
In FY 2013, PMI procured and distributed:
· approximately one million long-lasting insecticide-treated bed nets;
· 6.5 million artemisinin-based combination therapy doses, which treat uncomplicated malaria;
· 2.1 million doses of sulfadoxine-pyrimethamine, which prevents malaria during pregnancy; and
· 5.2 million rapid diagnostic test kits (RDTs), which detect evidence of malaria parasites in human blood.
PMI also trained health workers in case management and preventing malaria in pregnant women; treated pregnant women through antenatal care; mentored and provided supportive supervision to health care workers; conducted entomological monitoring in seven IRS districts; and helped finance the malaria indicator survey and treatment efficacy studies.
PMI partners with the MOH to ensure that the most recent evidence is translated into policy and program implementation.
Working towards universal access to preventation and treatment measures.
Funding (FY 2013)
- Ministry of Health
- John Snow Inc.
- Johns Hopkins University Population Services International
- Malaria Alert Centre
- Abt Associates
- Africa IRS
- DHS Measure 7
Last updated: July 15, 2014